Related Experiment Video
Updated: Jan 4, 2026
05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
608
Prostatectomy Versus Observation for Localized Prostate Cancer: A Meta-Analysis
Xiaojin Luo1, Meilian Yi2, Qun Hu3
1Department of Urology, The People's Hospital of Yichun City, Yichun, China.
Summary
Prostatectomy for localized prostate cancer significantly reduces the risk of death and disease progression. However, it increases the risk of erectile and urinary dysfunction, necessitating careful patient consideration.
Area of Science:
- Urology
- Oncology
- Evidence Synthesis
Background:
- Controversy exists regarding the benefits of prostatectomy for localized prostate cancer.
- Evaluating the role of prostatectomy in localized prostate cancer is crucial for treatment decisions.
Purpose of the Study:
- To evaluate the role of prostatectomy in localized prostate cancer patients.
- To synthesize evidence on the efficacy and adverse effects of prostatectomy versus observation.
Main Methods:
- Systematic literature search of PubMed and Web of Science.
- Included randomized controlled trials adhering to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines.
- Evidence synthesis for survival and adverse effects analysis.
Main Results:
- Prostatectomy decreased the risk of death by 9% (RR 0.91, P=0.007) and disease progression by 43% (RR 0.57, P<0.00001).
- No significant differences in psychological well-being or sense of meaningfulness were observed.
- Prostatectomy increased the risk of erectile dysfunction (RR 2.10, P=0.0009) and urinary problems (RR 2.02, P=0.01).
Conclusions:
- Prostatectomy offers survival and disease progression benefits for localized prostate cancer patients compared to observation.
- Key adverse effects include increased risks of erectile and urinary dysfunction.
- Treatment decisions require balancing survival benefits against the risk of functional impairment.
Related Concept Videos
01:21Cancer Survival Analysis
617
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
617
01:20Comparing the Survival Analysis of Two or More Groups
519
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
519